BNP Paribas Discount Zert LONN 26.../ DE000PC1R3T2 /
26/07/2024 10:12:14 | Chg.-0.89 | Bid14:16:05 | Ask14:16:05 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
405.73EUR | -0.22% | 405.31 Bid Size: 538 |
405.41 Ask Size: 538 |
LONZA N | - CHF | 26/06/2025 | Call |
GlobeNewswire
14/06
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at...
GlobeNewswire
30/05
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively licens...
GlobeNewswire
15/05
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ dec...
GlobeNewswire
08/05
Vaxcyte Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
04/04
Galapagos showcases innovative approach in hematological cancer care with clinical and translational...
GlobeNewswire
04/04
Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’...
GlobeNewswire
27/02
Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire
04/01
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further exp...
GlobeNewswire
19/12/2023
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufacture...
GlobeNewswire
09/12/2023
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire
07/12/2023
Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at A...
GlobeNewswire
06/11/2023
Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
16/10/2023
Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire
02/10/2023
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire
20/09/2023
Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
GlobeNewswire
07/09/2023
Institutional Investor Launches 2023 Developed Europe & Emerging Emea Executive Team Rankings